Bookmark

Add to MyYahoo RSS

Agrylin, Anagrelide News

News on Agrylin, Anagrelide (generic) continually updated from thousands of sources around the net.

Jan 13, 2014 | GlobeNewswire

Galena Biopharma Acquires Mills Pharmaceuticals, LLC

Galena Biopharma , a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, today announced it has acquired Mills Pharmaceuticals, which has the worldwide rights to GALE-401 , a patented, controlled release formulation of anagrelide.

Comment?

Related Topix: Medicine, Healthcare Law, Food and Drug Administration, Law

Mon Mar 18, 2013

biospace.com

AOP Orphan Pharmaceuticals AG Release: Essential Thrombocythemia (ET) ...

Anagrelide a selective platelet lowering agent is not inferior compared to hydroxyurea in preventing disease related complications in patients with WHO-ET. ANAHYDRET study data now provide evidence that anagrelide can be considered as first line therapy for lowering of platelet count in WHO-ET. High platelet counts in essential thrombocythemia can ... (more)

Comment?

Related Topix: Medicine, Hydrea, Hydroxyurea (generic), World News, Austria,

Sat Nov 05, 2011

CiteULike

Hydroxyurea Compared with Anagrelide in High-Risk Essential Thrombocythemia

353, No. 1. , pp. 33-45. The principal feature of essential thrombocythemia, a clonal hematologic stem-cell disorder,1?4 is thrombosis, with arterial events being more common than venous events.

1 comment

Related Topix: Medicine, Medication, Platelet Count, Health

•••
•••
•••
•••
•••
•••
•••